Design and Characterization of Atenolol Nanostructured Lipid Carriers for Oral Administration
Year: 2026
Type: article
Abstract: The present study aimed to design and characterize Atenolol loaded Nanostructured Lipid Carriers (NLCs) to enhance permeation and bioavailability. Atenolol, a BCS Class III drug with high solubility and low permeability, was incorporated into Nanostructured lipid carriers using the Solvent evaporation method. A Central Composite Design (CCD) was employed to optimize the formulation variables, including solid lipid and surfactant concentrations. The optimized formulation (F14) was evaluated for entrapment efficiency, particle size, zeta potential, in-vitro drug release, and morphology. The optimized NLCs formulation exhibited an entrapment efficiency of 83.93%, a drug release of 74.7% at 8 hours, and uniform vesicle morphology under SEM. The optimized NLCs were successfully incorporated into controlled release capsules, evaluation parameters were within pharmacopeial limits. The controlled release profile of the optimized capsules suggests the potential and achieve better blood pressure control. Overall, the study demonstrates that Atenolol-loaded NLCs are a promising strategy to improve bioavailability, reducing first-pass metabolism, controlled drug release, and provide an effective oral dosage form for hypertension management.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235218357
